IL18 and metabolic syndrome: Reduction in serum IL-18 levels across increasing numbers of +183 G-alleles (rs 5744292) is especially apparent in patient with diabetes type 2 and metabolic syndrome, suggesting a beneficial GG genotype in relation to cardiovascular outcome in these patients[73].